← Back to Catalog
Clinician access
Semaglutide
5mg
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Clinician Only
Metabolic & Foundational
Semaglutide
Semaglutide is a GLP-1 receptor agonist that mimics the body's natural incretin hormone to help regulate appetite, blood sugar, and insulin levels. It reduces hunger, slows gastric emptying, and supports fat loss while preserving lean mass.
Available Vials
- Delivery
- Subcutaneous Injection
- Starting Dose
- 0.25mg once weekly
- Titration
- Increase gradually by 0.25–0.5mg every 2–4 weeks
- Maintenance Range
- 1mg–2.5mg per week
- Sourcing
- Compounded in USA
Quantity
Continue Browsing1
More in Metabolic & Foundational
Tirzepatide
5mg
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Tirzepatide
Subcutaneous Injection
Retatrutide
5mg
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Retatrutide
Subcutaneous Injection
Cagrilintide
5mg
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Cagrilintide
Subcutaneous Injection
Sign in to view full clinical details
Reconstitution, contraindications, clinic pricing, patient handouts, monitoring cadence, and drug interactions are available to verified clinicians.